Healthcare Days Sales Outstanding from 2010 to 2024

HCTI Stock  USD 1.09  0.02  1.87%   
Healthcare Triangle's Days Sales Outstanding is increasing with stable movements from year to year. Days Sales Outstanding is estimated to finish at 67.67 this year. For the period between 2010 and 2024, Healthcare Triangle, Days Sales Outstanding quarterly trend regression had mean deviation of  9.58 and range of 64.5249. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
35.57329157
Current Value
67.67
Quarterly Volatility
14.77236579
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Healthcare Triangle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthcare Triangle's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 1 M or Selling General Administrative of 3.5 M, as well as many indicators such as Price To Sales Ratio of 0.33, Dividend Yield of 0.0 or PTB Ratio of 26.09. Healthcare financial statements analysis is a perfect complement when working with Healthcare Triangle Valuation or Volatility modules.
  
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.

Latest Healthcare Triangle's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Healthcare Triangle over the last few years. It is Healthcare Triangle's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Healthcare Triangle's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Pretty Stable
   Days Sales Outstanding   
       Timeline  

Healthcare Days Sales Outstanding Regression Statistics

Arithmetic Mean56.80
Geometric Mean55.31
Coefficient Of Variation26.01
Mean Deviation9.58
Median52.97
Standard Deviation14.77
Sample Variance218.22
Range64.5249
R-Value0.23
Mean Square Error222.99
R-Squared0.05
Significance0.42
Slope0.75
Total Sum of Squares3,055

Healthcare Days Sales Outstanding History

2024 67.67
2023 35.57
2022 44.48
2021 100.1
2020 74.5

About Healthcare Triangle Financial Statements

Investors use fundamental indicators, such as Healthcare Triangle's Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Healthcare Triangle's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Days Sales Outstanding 35.57  67.67 

Currently Active Assets on Macroaxis

When determining whether Healthcare Triangle offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthcare Triangle's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthcare Triangle Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthcare Triangle Stock:
Check out the analysis of Healthcare Triangle Correlation against competitors.
For more detail on how to invest in Healthcare Stock please use our How to Invest in Healthcare Triangle guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthcare Triangle. If investors know Healthcare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthcare Triangle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.17)
Revenue Per Share
4.813
Quarterly Revenue Growth
(0.65)
Return On Assets
(0.55)
Return On Equity
(2.88)
The market value of Healthcare Triangle is measured differently than its book value, which is the value of Healthcare that is recorded on the company's balance sheet. Investors also form their own opinion of Healthcare Triangle's value that differs from its market value or its book value, called intrinsic value, which is Healthcare Triangle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthcare Triangle's market value can be influenced by many factors that don't directly affect Healthcare Triangle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthcare Triangle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Healthcare Triangle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthcare Triangle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.